Michael Spannagl

8.4k total citations · 2 hit papers
130 papers, 5.8k citations indexed

About

Michael Spannagl is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michael Spannagl has authored 130 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 37 papers in Cardiology and Cardiovascular Medicine and 31 papers in Surgery. Recurrent topics in Michael Spannagl's work include Venous Thromboembolism Diagnosis and Management (31 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Michael Spannagl is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (31 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Michael Spannagl collaborates with scholars based in Germany, United States and Austria. Michael Spannagl's co-authors include Bernd Engelmann, Siegmund Braun, Ian A. Greer, Josef Georg Brecht, Emmanuel Oger, Frederick A. Anderson, Dominique Mottier, David Bergqvist, Juan I. Arcelus and Alexander T. Cohen and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Michael Spannagl

124 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venous thromboembolism (VTE) in Europe

2007 1.1k citations Michael Spannagl et al. Thrombosis and Haemostasis profile →
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases

2010 926 citations Siegmund Braun, Michael Spannagl et al. profile →

Peers

Countries citing papers authored by Michael Spannagl

Since Specialization

Citations

This map shows the geographic impact of Michael Spannagl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Spannagl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Spannagl more than expected).

Fields of papers citing papers by Michael Spannagl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Spannagl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Spannagl. The network helps show where Michael Spannagl may publish in the future.

Co-authorship network of co-authors of Michael Spannagl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Spannagl. A scholar is included among the top collaborators of Michael Spannagl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Spannagl. Michael Spannagl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New concept for control material in glucose point-of-care-testing for external quality assessment schemes 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), H. Rosenthal, (unknown), (unknown), Ingo Schellenberg, Michael Spannagl	0
2	Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results 2022 ·Clinical Biochemistry ·Lisa M. Johnson, Michael Spannagl, (unknown), Jürgen Durner	3
3	Antikoagulation in der Intensivmedizin 2021 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Patrick Möhnle, Mathias Bruegel, Michael Spannagl	1
4	Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays 2020 ·Journal of Thrombosis and Haemostasis ·Flora Peyvandi, Gili Kenet, (unknown), Rajiv K. Pruthi, Peter Ramge, Michael Spannagl	38
5	Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study 2017 ·Blood ·Katharina Holstein, (unknown), Paul Knöbl, Christiane Dobbelstein, Wolfgang Miesbach, Michael Spannagl, (unknown), Ute Scholz, Hermann Eichler, Angela Huth‐Kühne, Robert Klamroth, Armin Koch, Andreas Tiede	2
6	Implementation of a rapid HIT immunoassay at a university hospital – Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia 2017 ·Thrombosis Research ·Anne Black, Susanne Heimerl, (unknown), (unknown), Andreas Greinacher, Michael Spannagl, Wolfgang Herr, Christina Hart	1
7	Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C 2016 ·Cellular and Molecular Immunology ·(unknown), Joachim Pircher, Monika Merkle, Thomas Czermak, Andrea Ribeiro, Hanna Mannell, Florian Krötz, Alexandru A. Hennrich, Michael Spannagl, (unknown), Erik Gaitzsch, Markus Wörnle	12
8	Melanocyte antigen triggers autoimmunity in human psoriasis 2015 ·The Journal of Experimental Medicine ·Akiko Arakawa, Katherina Siewert, (unknown), Petra Besgen, (unknown), Geraldine Rühl, Jens Nickel, Sigrid Vollmer, Peter Thomas, Stefan Krebs, Stefan Pinkert, Michael Spannagl, Kathrin Held, Claudia Kammerbauer, Robert Besch, Klaus Dornmair, Jörg C. Prinz	261
9	Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C 2013 ·Virology Journal ·Axel Ulsenheimer, Gláucia Paranhos‐Baccalà, Florence Komurian-Pradel, Bijan Raziorrouh, (unknown), Helmut M. Diepolder, Roman Zachoval, Michael Spannagl, Maria–Christina Jung, Norbert H. Gruener	7
10	The Influence of Antithrombin Substitution on Heparin Sensitivity and Activation of Hemostasis During Coronary Artery Bypass Graft Surgery 2013 ·Anesthesia & Analgesia ·Wulf Dietrich, Raimund Busley, Michael Spannagl, Siegmund Braun, Tibor Schuster, Susanne Lison	10
11	Bridging with the Low molecular weight heparin certoparin in patients requiring temporary discontinuation of oral anticoagulation – the non-interventional, retrospective REMEMBER study 2012 ·Thrombosis Research ·R. Eiselé, Nima Melzer, (unknown), Peter Bramlage, Michael Spannagl	7
12	Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion 2011 ·The Annals of Thoracic Surgery ·Barbara Steinlechner, (unknown), Eva Base, Beatrice Birkenberg, Hendrik Jan Ankersmit, Michael Spannagl, Peter Quehenberger, M. Hiesmayr, Bernd Jilma	41
13	Molecular basis of antithrombin deficiency 2011 ·Thrombosis and Haemostasis ·Daniel Delev, Christof Geisen, Michael Spannagl, Manuela Krause, Wolfgang Miesbach, (unknown), Frauke Bergmann, (unknown), R. Großmann, Edelgard Lindhoff‐Last, E. Seifried, Johannes Oldenburg, Ànna Pavlova, Beate Luxembourg	78
14	Hemophilia A in Cardiac Operations: A Model of Reduced Thrombin Generation 2011 ·The Annals of Thoracic Surgery ·Susanne Lison, Michael Spannagl, Wulf Dietrich	12
15	Analysis of von Willebrand Factor Multimers by Simultaneous High- and Low-Resolution Vertical SDS-Agarose Gel Electrophoresis and Cy5-Labeled Antibody High-Sensitivity Fluorescence Detection 2010 ·American Journal of Clinical Pathology ·Helmut W. Ott, Andrea Griesmacher, (unknown), Georg Golderer, (unknown), Michael Spannagl, Burghardt Scheibe, Susanne Perkhofer, (unknown), Ulrich Budde	31
16	Hämostaseologisches Management beim Polytrauma – Stellenwert der patientennahen diagnostischen Methoden 2009 ·AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie ·Csilla Jámbor, Bernhard Heindl, Michael Spannagl, (unknown), (unknown), Thomas Frietsch	5
17	Anti-MICA Antibodies Are Related to Adverse Outcome in Heart Transplant Recipients 2009 ·The Journal of Heart and Lung Transplantation ·Teresa Kauke, Ingo Kaczmarek, Andrea Dick, Michael Schmoeckel, Marcus-André Deutsch, Andrés Beiras-Fernández, Bruno Reichart, Michael Spannagl	35
18	CU-2010—A Novel Small Molecule Protease Inhibitor with Antifibrinolytic and Anticoagulant Properties 2008 ·Anesthesiology ·Wulf Dietrich, (unknown), Andreas Koster, Michael Spannagl, (unknown), Andreas van de Locht	31
19	Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease 1996 ·Thrombosis Research ·Cornelia Reininger, J. Graf, Armin J. Reininger, Michael Spannagl, B. Steckmeier, L. Schweiberer	35
20	Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in open-heart surgery 1990 ·Anesthesiology ·Wolfgang Dietrich, Michael Spannagl, Marianne Jochum, P. Wendt, Wolfgang Schramm, (unknown), F. Sebening	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact